News Takeda woos Shire shareholders with increased bid Fourth and probably final bid has increased cash component
News Allergan says not interested in buying Shire Allergan has said it is not interested in buying Shire after all, after announcing yesterday that it was considering a bid for the UK-listed firm also targeted by Takeda.
Partner Content Partner Content 3 Key Reasons to Attend the 5th Drug Safety conference in Lo... Drug Safety
News Shire's $2.4bn oncology sell-off seen as Takeda spoiler Move seen as attempt to fend off Takeda takeover
News Takeda looks for loans to fund $40bn Shire takeover CEO Weber wants to turn Takeda into global pharma
News Repligen builds in cell therapy with $1.5bn BioLife takeover Repligen has reached a deal to buy cell therapy specialist BioLife Solutions for $1.5bn, tapping into a market growing at breakneck speed.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.
